In the first series of experiments MEK-directed siRNAs were used to selectively knock-down either MEK1 or MEK2, or both, in human melanoma SK-MEL-28 cells to determine the necessity of individual MEK signaling pathway for melanoma cell proliferation. This evidence concerns the gene MAP2K2 and melanoma.